DS
CMLTU

David Shaw’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

David Shaw’s Portfolio CMLTU Stock Details CMLTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,250,000
Closed -$13.7M – 5535
2021
Q2 		$13.7M Buy
+1,250,000
New +$13.5M 0.01% 1246

Other funds holding CMLTU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
AMH
Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

David Shaw's CMLTU Position: Q3 2021 in Review

David Shaw sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q3 2021, closing a stake of 1,250,000 shares — an estimated $13.7M sold.

David Shaw first reported a position in CMLTU in Q2 2021 and held it in 1 quarter. The position peaked at $13.7M in Q2 2021. 28 funds tracked by Wall St. Rank hold CMLTU as of Q3 2021.

  • David Shaw reported no remaining CM Life Sciences III Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • David Shaw sold 1,250,000 CM Life Sciences III Inc. Unit shares in Q3 2021, an estimated $13.7M.
  • David Shaw first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 1 quarter.
  • David Shaw's CM Life Sciences III Inc. Unit position peaked at $13.7M in Q2 2021.
  • 28 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.